研究成果Achievements

2021年度

  1. Minoura K, Abe K, Hyunha N, Nishikawa H, and Shimamura T,​​​​
    A mixture-of-experts deep generative model for integrated analysis of single-cell multiomics data
    Cell Reports Methods 2021 10.1016/j.crmeth.2021.100071.
  2. Ejima K, Kim KS, Ludema C, Bento AI, Iwanami S, Fujita Y, Ohashi H, Koizumi Y, Watashi K, Aihara K, Nishiura H, Iwami S.
    Estimation of the incubation period of COVID-19 using viral load data.
    Epidemics. 2021 Jun;35:100454. doi:10.1016/j.epidem.2021.100454.
  3. Ejima K, Koizumi Y, Yamamoto N, Rosenberg M, Ludema C, Bento AI, Yoneoka D, Ichikawa S, Mizushima D, Iwami S.
    HIV Testing by Public Health Centers and Municipalities and New HIV Cases During the COVID-19 Pandemic in Japan.
    J Acquir Immune Defic Syndr. 2021 Jun 1;87(2):e182-e187. doi:10.1097/QAI.0000000000002660. 
  4. Sakane A, Yano TA, Uchihashi T, Horikawa K, Hara Y, Imoto I, Kurisu S, Yamada H, Takei K, Sasaki T.
    JRAB/MICAL-L2 undergoes liquid-liquid phase separation to form tubular recycling endosomes.
    Commun Biol. 2021 May 11;4(1):551. doi:10.1038/s42003-021-02080-7. PMID: 33976349; PMCID: PMC8113518.
  5. Ohashi H, Watashi K, Saso W, Shionoya K, Iwanami S, Hirokawa T, Shirai T, Kanaya S, Ito Y, Kim KS, Nomura T, Suzuki T, Nishioka K, Ando S, Ejima K, Koizumi Y, Tanaka T, Aoki S, Kuramochi K, Suzuki T, Hashiguchi T, Maenaka K, Matano T, Muramatsu M, Saijo M, Aihara K, Iwami S, Takeda M, McKeating JA, Wakita T.
    Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment.
    iScience. 2021 Apr 23;24(4):102367. doi:10.1016/j.isci.2021.102367.
  6. Torii S, Ono C, Suzuki R, Morioka Y, Anzai I, Fauzyah Y, Maeda Y, Kamitani W, Fukuhara T, Matsuura Y.
    Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction.
    Cell Rep. 2021 Apr 20;35(3):109014. doi: 10.1016/j.celrep.2021.109014.

To be scheduled.

To be scheduled.

To be scheduled.